Danimer Scientific is a company that manufactures PHA biopolymers using renewable resources in order to reduce global dependence on petroleum. Founded in 2004 and headquartered in the United States, the company produces bioplastics from renewable, natural resources.
Danimer Scientific's bioplastics are 100% biodegradable and compostable, and they match or exceed petroleum-based plastic commodities in terms of price and performance. The company creates bioplastic feedstock from canola oil, enabling global brand owners to integrate environmentally responsible materials into their everyday products.
Moreover, Danimer Scientific offers specialty toll manufacturing at their facility, providing state-of-the-art production equipment, laboratories, material handling and logistics, as well as fully trained and experienced staff to other companies. They use the customer's formulations, materials, and instruction to produce quality products to the client's specifications.
With a recent grant investment at 24 September 2024, Danimer Scientific is poised to further their mission of offering a scalable, durable, and cost-effective material that reduces manufacturing dependence on non-renewable resources. The company operates in the biotechnology, life sciences, and medical devices industries, positioning itself as an important player in the sustainability-focused market.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | Unknown | - | 24 Sep 2024 | |
Grant | Unknown | - | 27 Jun 2024 | |
Post-IPO Debt | Unknown | - | 19 Apr 2024 | |
Post-IPO Debt | Unknown | - | 20 Mar 2023 | |
Post-IPO Equity | Unknown | - | 29 Dec 2020 |
No recent news or press coverage available for Danimer Scientific.